CVE-2026-25720: SenseLive X3050 · Insufficient Session Expiration
Affects SenseLive X3050Source CVE Database V5
Not known to be exploited · CVSS 6.9 Medium.
Data as of 30 Oct 2026, 11:52 UTC
- EPSS
- 0.2% chance of exploitation in 30 days – higher than 20% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 23 Apr 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| SenseLiveX3050 | Affected
| Fixed in– |
GitHubsenselive/x3050pkg:github/senselive/x3050Other threats | Affected
| Fixed in– |
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
Until an official fix is released, organizations should consider limiting access to the management interface, using network controls to restrict session exposure, and enforcing manual session termination where possible.
Description
CVE-2026-25720 is a medium severity vulnerability in the SenseLive X3050 web management interface caused by insufficient session expiration. Authenticated sessions remain active for extended periods without requiring re-authentication, allowing an attacker with access to a previously authenticated session to continue administrative interactions after legitimate user activity has ended. There is no confirmed patch or official remediation available at this time.